3don MSN
Merck KGaA is paying more than double for this gene-silencing biotech, which is soaring 125%
Silence Therapeutics stock surges as Merck KGaA agrees to acquire the RNA drugmaker for over $1 billion.
By Christy Santhosh Oct 19 (Reuters) - German drugmaker Merck KGaA said on Monday it would acquire UK-based Silence ...
Merck Collaborates with NVIDIA, Microsoft and Dawn Health to Develop Novel Support Model for People Living with Rare Tumors .bwlistdisc { list-style-type: disc } ...
Merck officially introduced a $500 million, 120,000-square-foot research building featuring automated robotics systems and ...
The 130-year-old drugmaker is using Proto’s life-size displays and AI avatars to bring disease-awareness campaigns to ...
Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Merck & Co., Inc. - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. Merck & Co., Inc. (Merck) is ...
Moderna (MRNA) stock crashed Thursday after a third-party leaked the purported cancer vaccine data ahead of a ...
Technology is changing the way pharmaceutical companies discover and develop new drugs. For Matt Studney, who joined Merck as a chemical engineer, technology changed the course of his career. In 2017, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results